{
  "licence": "CC BY 4.0",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "canonical_url": "https://www.acquiry.com/api/hidden-acquisitions/v1/deals/sktelecom-imprimed-2023.json",
  "version": "1.0.1",
  "generated_at": "2026-11-17T01:37:18.223Z",
  "attribution": "Source: Hidden Acquisitions Index, Acquiry Labs (CC BY 4.0)",
  "data": {
    "deal_id": "sktelecom-imprimed-2023",
    "announce_date": "2023-11-06",
    "acquirer": "SK Telecom",
    "acquirer_country": "South Korea",
    "target": "ImpriMed",
    "target_country": "United States",
    "target_focus": "AI models for predicting responses to cancer treatments.",
    "deal_type": "OTHER_HYBRID",
    "licence_included": "not disclosed",
    "licence_exclusive": "not disclosed",
    "equity_stake_pct": "not disclosed",
    "disclosed_value_usd": 3000000,
    "value_scope": "Buyer-specific investment, using the issuer’s stated US dollar amount.",
    "value_basis": "point",
    "founders_moved": [],
    "staff_moved": "not disclosed",
    "structure_facts": "SK Telecom bought equity alongside a strategic partnership covering AI healthcare.",
    "remainder_after": "not disclosed",
    "remainder_date": "not disclosed",
    "remainder_valuation_after_usd": "not disclosed",
    "payout_detail": "not disclosed",
    "regulatory_review": "not disclosed",
    "regulator_doc_url": "not disclosed",
    "buyer_tier": "core: large listed buyer",
    "notes": "not disclosed",
    "target_status_after": "not disclosed",
    "regulatory_events": [],
    "completeness": "full",
    "source_round": "ChatGPT round 2",
    "index_tier": "extended",
    "sources": [
      {
        "n": 1,
        "publisher": "SK Telecom",
        "title": "",
        "date": "2023-11-06",
        "grade": "A",
        "url": "https://news.sktelecom.com/199456",
        "quote": "임프리메드(ImpriMed)",
        "supports": [
          "acquirer",
          "announce_date",
          "buyer_tier",
          "deal_id",
          "deal_type",
          "disclosed_value_usd",
          "equity_stake_pct",
          "founders_moved",
          "licence_exclusive",
          "licence_included",
          "notes",
          "payout_detail",
          "regulator_doc_url",
          "regulatory_review",
          "remainder_after",
          "remainder_date",
          "remainder_valuation_after_date",
          "remainder_valuation_after_usd",
          "staff_moved",
          "structure_facts",
          "target",
          "target_country",
          "target_focus",
          "target_status_after",
          "tier_evidence",
          "value_basis",
          "value_scope"
        ],
        "live_check": {
          "source_id": "sktelecom-imprimed-2023-S01",
          "retrieved_at_utc": "2026-11-15T11:10:56.155Z",
          "quote_match": "exact",
          "quote_location": "reader line 55"
        },
        "archive_url": null,
        "independent_check": {
          "checker": "verify_sources.py (deterministic)",
          "checked_at_utc": "2026-11-16T00:01:46Z",
          "result": "exact",
          "method": "live",
          "score": "100"
        }
      },
      {
        "n": 2,
        "publisher": "SEC issuer directory, SK Telecom",
        "title": "",
        "date": "",
        "grade": "A",
        "url": "https://data.sec.gov/submissions/CIK0001015650.json",
        "quote": "\"country\":\"Korea, Republic of\"",
        "supports": [
          "acquirer_country"
        ],
        "live_check": {
          "source_id": "sktelecom-imprimed-2023-S2",
          "retrieved_at_utc": "2026-11-15T18:21:53Z",
          "quote_match": "exact",
          "quote_location": "EDGAR addresses.business.country",
          "verifier": "chatgpt"
        },
        "archive_url": null,
        "independent_check": {
          "checker": "verify_sources.py (deterministic)",
          "checked_at_utc": "2026-11-16T00:01:46Z",
          "result": "exact",
          "method": "live",
          "score": "100"
        }
      },
      {
        "n": 3,
        "publisher": "SK Telecom",
        "title": "",
        "date": "2023-11-06",
        "grade": "A",
        "url": "https://news.sktelecom.com/199456",
        "quote": "‘임프리메드’에 약 40억원(3백만 달러)을 각각 투자하고 지분을 확보했다.",
        "supports": [
          "disclosed_value_usd"
        ],
        "derivative_of": "",
        "archive_url": null,
        "value_supported": "3000000 USD | investment | ImpriMed allocation only. issuer gives USD and approximate KRW equivalents",
        "live_check": {
          "source_id": "sktelecom-imprimed-2023-R4-3",
          "retrieved_at_utc": "2026-11-15T12:13:00Z",
          "quote_match": "exact",
          "quote_location": "HTML text, paragraph 86",
          "verifier": "chatgpt"
        },
        "independent_check": {
          "checker": "verify_sources.py (deterministic)",
          "checked_at_utc": "2026-11-16T00:01:46Z",
          "result": "exact",
          "method": "live",
          "score": "100"
        }
      },
      {
        "n": 4,
        "publisher": "ImpriMed",
        "title": "",
        "date": "",
        "grade": "A",
        "url": "https://www.imprimedicine.com/about-us",
        "quote": "Palo Alto Headquarters",
        "supports": [
          "target_country",
          "threshold_jurisdiction"
        ],
        "derivative_of": "",
        "archive_url": null,
        "value_supported": "United States",
        "live_check": {
          "source_id": "sktelecom-imprimed-2023-R5-4",
          "retrieved_at_utc": "2026-11-15T18:51:40.019Z",
          "quote_match": "exact",
          "quote_location": "reader line 282",
          "verifier": "chatgpt"
        },
        "independent_check": {
          "checker": "verify_sources.py (deterministic)",
          "checked_at_utc": "2026-11-16T00:01:46Z",
          "result": "exact",
          "method": "live",
          "score": "100"
        }
      }
    ],
    "value_source_grade": "A",
    "tier_reason": "The current evidence establishes investment and commercial collaboration. It does not establish a listed qualifying control right. The type should not assert control.",
    "headline_check": {
      "acquirer": "primary",
      "target": "primary",
      "announce_date": "primary",
      "deal_type": "primary",
      "structure_facts": "primary"
    },
    "money_components": [
      {
        "original_amount": "3000000",
        "currency": "USD",
        "money_type": "investment",
        "tranche_or_cumulative": "ImpriMed allocation only. issuer gives USD and approximate KRW equivalents",
        "url": "https://news.sktelecom.com/199456",
        "quote_exact": "‘임프리메드’에 약 40억원(3백만 달러)을 각각 투자하고 지분을 확보했다."
      }
    ],
    "deal_type_previous": "MINORITY_STAKE_CONTROL",
    "tier_rule": "Extended: investment plus commercial tie-in",
    "field_notes": {
      "acquirer_country": "issuer business-address country, direct or SEC code lookup",
      "target_country": "explicit Palo Alto headquarters label separate from Seoul office",
      "threshold_jurisdiction": "explicit Palo Alto headquarters label separate from Seoul office; country proxy only, no conclusion about filing obligation"
    },
    "threshold_jurisdiction": "United States",
    "date_precision": "day",
    "date_basis": "not disclosed",
    "dma_notification_date": null,
    "conflicts": [],
    "advisers": []
  }
}
